Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
IMVT

IMVT - Immunovant Inc Stock Price, Fair Value and News

$26.09-0.74 (-2.76%)
Market Closed

Price Targets

IMVT Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

IMVT Price Action

Last 7 days

0.3%

Last 30 days

1.9%

Last 90 days

5.1%

Trailing 12 Months

18.4%

IMVT RSI Chart

IMVT Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

IMVT Valuation

Market Cap

4.6B

Price/Earnings (Trailing)

-9.84

EV/EBITDA

-8.77

Price/Free Cashflow

-10.6

MarketCap/EBT

-9.89

IMVT Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

IMVT Fundamentals

IMVT Earnings

Earnings (TTM)

-464.7M

Earnings Growth (Yr)

-15.93%

Earnings Growth (Qtr)

-4.88%

IMVT Profitability

Return on Equity

-89.41%

Return on Assets

-79.71%

Free Cashflow Yield

-9.43%

IMVT Investor Care

Shares Dilution (1Y)

19.41%

Diluted EPS (TTM)

-2.83

About Immunovant Inc

IMVT
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as completed initiation of Phase II clinical trials for the treatment of warm autoimmune hemolytic anemia. The company was incorporated in 2018 is headquartered in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.
 CEO
 WEBSITEhttps://immunovant.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES164

Immunovant Inc Frequently Asked Questions

IMVT is the stock ticker symbol of Immunovant Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Immunovant Inc is 4.57 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check IMVT's fair value in chart for subscribers.

The fair value guage provides a quick view whether IMVT is over valued or under valued. Whether Immunovant Inc is cheap or expensive depends on the assumptions which impact Immunovant Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for IMVT.